Laminin-5 β3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity

Neoplasia

Volumn 6, Issue 5, 2004, Pages 468-479

  Calaluce, Robert ^a,b   Bearss, David J ^a,b   Barrera, Jean ^b   Zhao, Yu ^a   Han, Haiyong ^a,b   Beck, Shaleen K ^a   McDaniel, Kathy ^a   Nagle, Ray B ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cell migration; Laminin 5 3A; LNCaP; Prostate carcinoma cells; Tumorigenicity

Indexed keywords

ALPHA6BETA4 INTEGRIN; COMPLEMENTARY DNA; KALININ; LAMININ 5 BETA3A; UNCLASSIFIED DRUG; ALPHA6 INTEGRIN; CELL ADHESION MOLECULE; ISOPROTEIN;

ARTICLE; BASAL CELL; CANCER CELL CULTURE; CARCINOGENICITY; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CONTROLLED STUDY; DNA MICROARRAY; GENETIC TRANSFECTION; HEMIDESMOSOME; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; ANIMAL; BIOASSAY; BIOSYNTHESIS; CARCINOMA; CELL ADHESION; CELL MEMBRANE; CELL MOTION; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL ASSAY; CARCINOMA; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; GENE EXPRESSION PROFILING; HUMANS; INTEGRIN ALPHA6; MALE; MICE; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 6944238581     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.03499     Document Type: Article

References (61)

1. Ingber DE, Madri JA, and Jamieson JD (1981). Role of basal lamina in neoplastic disorganization of tissue architecture. Proc Natl Acad Sci USA 78, 3901-3905.
2. Lukashev ME and Werb Z (1998). ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8, 437-441.
3. Knox JD, Cress AE, Clark V, Manriquez L, Affinito KS, Dalkin BL, and Nagle RB (1994). Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol 145, 167-174.
4. Nagle RB, Hao J, Knox JD, Dalkin BL, Clark V, and Cress AE (1995). Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 146, 1498-1507.
5. Ferletta M and Ekblom P (1999). Identification of laminin-10/11 as a strong cell adhesive complex for a normal and a malignant human epithelial cell line. J Cell Sci 112 (Pt 1), 1-10.
6. Campbell KP (1995). Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675-679.
7. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, and Sanes JR (1990). Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1, 731-740.
8. Sanes JR, Engvall E, Butkowski R, and Hunter DD (1990). Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 111, 1685-1699.
9. Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, and Uitto J (1994). Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 6, 293-297.
10. Pulkkinen L, Christiano AM, Gerecke D, Wagman DW, Burgeson RE, Pittelkow MR, and Uitto J (1994). A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 24, 357-360.
11. Aberdam D, Galliano MF, Vailly J, Pulkkinen L, Bonifas J, Christiano AM, Tryggvason K, Uitto J, Epstein EH Jr, Ortonne JP, and Meneguzzi G (1994). Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet 6, 299-304.
12. Kivirikko S, McGrath JA, Baudoin C, Aberdam D, Ciatti S, Dunnill MG, McMillan JR, Eady RA, Ortonne JP, and Meneguzzi G (1995). A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 4, 959-962.
13. McGarth JA, Christiano AM, Pulkkinen L, Eady RA, and Uitto J (1996). Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. J Invest Dermatol 106, 1157-1159.
14. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, and Tryggvason K (1995). Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55, 4132-4139.
15. Jones JCR, Hopkinson SB, and Goldfinger LE (1998). Structure and assembly of hemidesmosomes. Bioessays 20, 488-494.
16. Matsui C, Wang CK, Nelson CF, Bauer EA, and Hoeffler WK (1995). The assembly of laminin-5 subunits. J Biol Chem 270, 23496-23503.
17. Carter WG, Ryan MC, and Gahr P (1991). Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 65, 599-610.
18. Gehlsen KR, Sriramarao P, Furcht LT, and Skubitz AP (1992). A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin. J Cell Biol 117, 449-459.
19. Nomizu M, Kim WH, Yamamura K, Utani A, Song SY, Otaka A, Roller PP, Kleinman HK, and Yamada Y (1995). Identification of cell binding sites in the laminin α1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J Biol Chem 270, 20583-20590.
20. Pattaramalai S, Skubitz KM, and Skubitz AP (1996). A novel recognition site on laminin for the α3β1 integrin. Exp Cell Res 222, 281-290.
21. Kramer RH, Vu MP, Cheng YF, Ramos DM, Timpl R, and Waleh N (1991). Laminin-binding integrin α7β1: functional characterization and expression in normal and malignant melanocytes. Cell Regul 2, 805-817.
22. Mainiero F, Pepe A, Wary KK, Spinardi L, Mohammadi M, Schlessinger J, and Giancotti FG (1995). Signal transduction by the alpha 6 beta 4 integrin: distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J 14, 4470-4481.
23. Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, Blumemberg M, Westwick JK, Der CJ, and Giancotti FG (1997). The coupling of alpha6-beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 16, 2365-2375.
24. Clark EA and Brugge JS (1995). Integrins and signal transduction pathways: the road taken. Science 268, 233-239.
25. Dedhar S, Williams B, and Hannigan G (1999). Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol 9, 319-323.
26. Giancotti FG and Ruoslahti E (1999). Integrin signaling. Science 285, 1028-1032.
27. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, and Quarante V (1997). Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228.
28. Goldfinger LE, Stack MS, and Jones JCR (1998). Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol 141, 255-265.
29. Goldfinger LE, Hopkinson SB, deHart GW, Collawn S, Couchman JR, and Jones JCR (1999). The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 112, 2615-2629.
30. Grassi M, Moens G, Rousselle P, Thiéry JP, and Jouanneau J (1999). The SFL activity secreted by metastatic carcinoma cells is related to laminin 5 and mediates cell scattering in an integrin-independent manner. J Cell Sci 112, 2511-2520.
31. Fine JD, Bauer EA, Briggaman RA, Carter DM, Eady RA, Esterly NB, Holbrook KA, Hurwitz S, Johnson L, Lin A, et al. (1991). Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 24, 119-135.
32. Ryan MC, Lee K, Miyashita Y, and Carter WG (1999). Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 145, 1309-1323.
33. Fukushima Y, Ohnishi T, Arita N, Hayakawa T, and Sekiguchi K (1998). Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration, and invasion of malignant glioma cells. Int J Cancer 76, 63-72.
34. Tani T, Lumme A, Linnala A, Kivilaakso E, Kiviluoto T, Burgeson RE, Kangas L, Leivo I, and Virtanen I (1997). Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol 151, 1289-1302.
35. Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K, and Tryggvason K (1994). The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145, 782-791.
36. Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, and Sordat B (1998). Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 185, 44-52.
37. Bahadoran P, Perrin C, Aberdam D, Spadafora-Pisani A, Meneguzzi G, and Ortonne JP (1997). Altered expression of the hemidesmosome-anchoring filament complex proteins in basal cell carcinoma: possible role in the origin of peritumoral lacunae. Br J Dermatol 136, 35-42.
38. Chopra A, Maitra B, and Korman NJ (1998). Decreased mRNA expression of several basement membrane components in basal cell carcinoma. J Invest Dermatol 110, 52-56.
39. Martin KJ, Kwan CP, Nagasaki K, Zhang X, O'Hare MJ, Kaelin CM, Burgeson RE, Pardee AB, and Sager R (1998). Down-regulation of laminin-5 in breast carcinoma cells. Mol Med 4, 602-613.
40. Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB, and Bowden GT (2003). Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res 63, 2292-2299.
41. Hao J, Yang Y, McDaniel KM, Dalkin BL, Cress AE, and Nagle RB (1996). Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol 149, 1341-1349.
42. Hao J, McDaniel K, Weyer C, Barrera J, and Nagle RB (2002). Cell-line specific translation of two laminin 5 β3 chain isoforms. Gene 283, 237-244.
43. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, and Danielsen M (1987). Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84, 7413-7417.
44. Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden GT, Cress AE, Futscher BW, and Nagle RB (2001). Laminin-5 mediated gene expression in human prostate carcinoma cells. Mol Carcinog 30, 119-129.
45. Schmelz M, Cress AE, Barrera J, McDaniel KM, Davis TL, Fuchs L, Dalkin BL, and Nagle RB (2001). PEAZ-1: a new human prostate neoplastic epithelial cell line. Prostate 48, 79-92.
46. Mizushima H, Hirosaki T, Miyata S, Takamura H, Miyagi Y, and Miyazaki K (2002). Expression of laminin-5 enhances tumorigenicity of human fibrosarcoma cells in nude mice. Jpn J Cancer Res 93, 652-659.
47. Gagnoux-Palacios L, Vailly J, Durand-Clement M, Wagner E, Ortonne J-P, and Meneguzzi G (1996). Functional re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem 271, 18437-18444.
48. Vailly J, Gagnoux-Palacios L, Dell'Ambra E, Romero C, Pinola M, Zambruno G, DeLuca M, Ortonne J-P, and Meneguzzi G (1998). Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther 5, 1322-1332.
49. Robbins PB, Lin Q, Goddnough JB, Tian H, Chen X, and Khavari PA (2001). In vivo restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa. PNAS 98, 5193-5198.
50. Rabinowitz I, Cress AE, and Nagle RB (1994). Biosynthesis and secretion of laminin and S-laminin by human prostate carcinoma cell lines. Prostate 25, 97-107.
51. Rabinovitz I, Nagle RB, and Cress AE (1995). Integrin α6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clin Exp Metastasis 13, 481-491.
52. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC, Otey CA, Zhau HE, and Chung LWK (2001). Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 12, 99-107.
53. Lawler S (1999). Regulation of actin dynamics: the LIM kinase connection. Curr Biol 9, R800-802.
54. Yoshioka K, Foletta V, Bernard O, and Itoh K (2003). A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 100, 7247-7252.
55. Davila M, Frost AR, Grizzle WE, and Chakrabarti R (2003). LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 278, 36868-36875.
56. Tran NL, Nagle RB, Cress AE, and Heimark RL (1999). N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155, 787-798.
57. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, and Schalken JA (2000). Cadherin switching in human prostate cancer progression. Cancer Res 60, 3650-3654.
58. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, and Chinnaiyan AM (2001). Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826.
59. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, and Quaranta V (2003). Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161, 197-209.
60. Olumi AF, Dazin P, and Tlsty TD (1998). A novel coculture technique demonstrates that normal human prostatic fibroblasts contribute to tumor formation of LNCaP cells by retarding cell death. Cancer Res 58, 4525-4530.
61. Hanahan D and Weinberg RA (2000). The hallmarks of cancer. Cell 100, 57-70.